ISCHEMIC NEUROLOGICAL INTERVENTIONAL MEDICAL DEVICES MARKET ANALYSIS
Global Biopharmaceutical and Biomedicine Market: Key Developments
The increasing product launches and approvals are expected to drive the market growth over the forecast period. For instance, in April 2021, VESALIO, LLC ., a company treating stroke and vascular occlusions, initiated a clinical trial to assess the safety, performance and efficacy of NeVa stent retriever a device used to remove the thrombus in patients with ischemic stroke and will be completing the trial in December 2022.
The increasing research and development activities for the development of ischemic neurological interventional medical devices and technologies is expected to drive the market growth over the forecast period. For instance, in January 2022, STROKE: Vascular and Interventional Neurology , an article Published on behalf of the American Heart Association, Inc., and the Society of Vascular and Interventional Neurology by Wiley Periodicals LLC., focused on the paced of advancements and the anticipated trials with the results of acute ischemic stroke.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowPress Release
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
